US OptionsDetailed Quotes

PNR250516P55000

Watchlist

0.00
0.000.00%

15min DelayClose May 2 09:30 ET

0.00High0.00Low

Pentair Stock Discussion

Moomoo AI

Jan 31, 2024 20:17

Despite Pentair's lower predicted growth, its high P/E ratio indicates investor optimism. However, this may not be sustainable as predicted earnings growth may not support the high P/E ratio, posing a risk to shareholders.

Pentair Plc's (NYSE:PNR) Share Price Not Quite Adding Up

Moomoo AI

Jan 17, 2024 01:12

Despite EPS growth outpacing share price increase, market enthusiasm for the stock seems to be waning. However, the company's positive total shareholder return indicates rewarding of shareholders. Recent sentiment around the company appears positive, suggesting business momentum.

Investing in Pentair (NYSE:PNR) Five Years Ago Would Have Delivered You a 86% Gain

Moomoo AI

Jan 2, 2024 00:18

Pentair's future looks promising despite share price oscillation. Factor in elements like balance sheet strength for potential investment, as the current price may not be optimal for purchasing.

What Is Pentair Plc's (NYSE:PNR) Share Price Doing?

Moomoo AI

Dec 17, 2023 22:43

Pentair's standout ROE and reinvestment has spurred significant earnings growth. Continuing dividend payments indicate the company's shareholder commitment. Analysts forecast sustained growth reflected in future ROE predictions.

Is Pentair Plc's (NYSE:PNR) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Moomoo AI

Nov 17, 2023 00:16

Pentair's steady returns may seem mundane, yet might reward shareholders long-term. Investors recognize positive trends, further research could expose more potential.

Investors Met With Slowing Returns on Capital At Pentair (NYSE:PNR)

areecep

Oct 25, 2023 11:51

Imagine investing equal amounts of money in the Dividend Aristocrats list from 2012 in your retirement account at the very end of 2012

You turn the DRIP on, and let compounding do its work. You do nothing for 10 years. Only exception is to reinvest money in all the aristocrats for any company that's acquired
You generate a decent return over time
$Warren Buffett Portfolio (LIST2999.US)$ $Berkshire Hathaway-A (BRK.A.US)$ $Berkshire Hathaway-B (BRK.B.US)$ $Coca-Cola (KO.US)$ $Cintas (CTAS.US)$ $S&P Global (SPGI.US)$ $McDonald's (MCD.US)$ $Johnson & Johnson (JNJ.US)$ $PepsiCo (PEP.US)$ $Procter & Gamble (PG.US)$ $Target (TGT.US)$ $Walmart (WMT.US)$ $Pentair (PNR.US)$ $Chevron (CVX.US)$ $Stanley Black & Decker (SWK.US)$ $3M (MMM.US)$ $VF Corp (VFC.US)$

Analysts Notebook

Jun 29, 2023 19:45

Columns US Top Rating Updates on 6/29: FREY, MU, PFE, DIS and More

$Pentair (PNR.US)$ initiated at buy by Deutsche Bank, announced target price at $75.00.
$Roku Inc (ROKU.US)$ initiated at neutral by Piper Sandler, announced targe price at $65.00.
$FREYR Battery (FREY.US)$ was upgraded by Morgan Stanley from equal-weight to overweight, increased target price to $13.00.
$Micron Technology (MU.US)$ was upgraded by Piper Sandler from underweight to neutral, increased target price from $45.00 to $70.00.
$Pfizer (PFE.US)$ was downg...

Analysts Notebook

Dec 19, 2022 20:14

Columns US Top Rating Updates on 12/19: TSLA, T, MRNA, XYL and More

Moderna Upgraded to Buy From Hold at Jefferies
Jefferies analyst Michael Yee upgraded $Moderna (MRNA.US)$ to Buy from Hold with a price target of $275, up from $170. The shares can rebound in 2023 given the company's pipeline opportunities, Yee tells investors in a research note. He believes Moderna is the "new shiny thing" in personalized cancer vaccine following the recent positive Phase 2 data.
Atlantic Upgrades Warner Music on 'Solid...

Mooers Radar

Dec 2, 2022 17:09

Columns US Top Gap Ups and Downs on 12/1: PUK, NEM, DG, CRM and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Okta (OKTA.US)$ - up 14.96%
2. $Five Below (FIVE.US)$ - up 8.79%
3. $Splunk (SPLK.US)$ - up 8.74%
4. $Prudential (PUK.US)$ - up 3.25%
5. $James Hardie Industries (JHX.US)$ - up 2.66%
6. $Synopsys (SNPS.US)$ - up 2.49%
7. $Diageo (DEO.US)$ - up 1.62%
8. $Fresenius Medical Care (FMS.US)$ - up 1.53...